Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $29.1200 (-3.13%) ($29.0200 - $30.3000) on Wed. Jul. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.86% (three month average) | RSI | 52 | Latest Price | $29.1200(-3.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.7% a day on average for past five trading days. | Weekly Trend | IOVA advances 1.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(46%) ARKG(44%) IWO(42%) ARKK(40%) | Factors Impacting IOVA price | IOVA will decline at least -1.93% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-12%) TBT(-5%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.93% (StdDev 3.86%) | Hourly BBV | 0 () | Intraday Trend | -2.6% | | | |
|
Resistance Level | $29.27 | 5 Day Moving Average | $30.18(-3.51%) | 10 Day Moving Average | $29.87(-2.51%) | 20 Day Moving Average | $29.27(-0.51%) | To recent high | -29% | To recent low | 7% | Market Cap | $4.264b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |